Mean scores, standard deviations, and significance on key measures and subscales by gender group. by Silas Manning (22693338)

Subjects:

Classical sensitivity values. by Bernd Porr (32394)

JF values. by Bernd Porr (32394)

Comparing detector performance against increasing signal to noise ratios. by Bernd Porr (32394)

Potato gene ontology enrichment results significant at <i>p</i> < 0.01. by Margaret A. Carpenter (6104180)

Genome-wide significant SNPs for meat L*15 min and a*15 min. by Jiahong Sun (6497603)

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Authority Groups. by David Vagni (8060432)

Subjects:

Statistically Significant Results for Heart Rate Variability (HRV) Indices for High and Low Clarity Groups. by David Vagni (8060432)

Subjects:

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Main baseline characteristics of patients included in the study. by Jie Liu (15128)

Subjects:

(A) Monthly drug costs of patients in the ESAs group and Roxadustat group. by Jie Liu (15128)

Subjects:

Study data. by Jie Liu (15128)

Subjects:

Mean hemoglobin levels of Roxadustat and ESAs groups over time. by Jie Liu (15128)

Subjects:

Morisky score for ESAs group and Roxadustat group. by Jie Liu (15128)

Subjects:

Patient flow diagram. by Jie Liu (15128)

Subjects:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

Subjects:

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

Subjects:

Approval by the research ethics committee. by Jie Liu (15128)

Subjects:

(A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups. by Jie Liu (15128)

Subjects: